See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2015_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,796,029,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 841,119,000 |
| 2 | PropertyPlantAndEquipmentNet | 392,248,000 |
| 3 | remainder_Assets | 172,566,000 |
| 4 | LiabilitiesCurrent | 606,740,000 |
| 5 | LiabilitiesNoncurrent | 62,634,000 |
| 6 | remainder_Liabilities | 230,570,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 707,886,718 |
| 9 | ResearchAndDevelopmentExpense | 1,215,748,965 |
| 10 | remainder_Expenses | 418,389,560 |
| 11 | remainder_Revenues | 3,354,553,125 |
| 12 | remainder_NetIncome | 900,110 |
| 13 | remainder_ComprehensiveNetIncome | -29,463,845 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,201,962,000 |
| 1 | Liabilities | 899,944,000 |
| 2 | Expenses | 2,342,025,243 |
| 3 | Revenues | 3,354,553,125 |
| 4 | StockholdersEquity | 3,302,018,000 |
| 5 | NetIncome | 1,013,427,992 |
| 6 | ComprehensiveNetIncome | 998,696,070 |
| 7 | BaseVar | 5,414,424,162 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.21 |
| 9 | EconomicCapitalRatio | 3.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
